GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Quantum-Si Inc (NAS:QSI) » Definitions » 3-Year RORE %

Quantum-Si (Quantum-Si) 3-Year RORE % : -23.66% (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Quantum-Si 3-Year RORE %?

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. Quantum-Si's 3-Year RORE % for the quarter that ended in Dec. 2023 was -23.66%.

The industry rank for Quantum-Si's 3-Year RORE % or its related term are showing as below:

QSI's 3-Year RORE % is ranked worse than
69.18% of 1392 companies
in the Biotechnology industry
Industry Median: -5.96 vs QSI: -23.66

Quantum-Si 3-Year RORE % Historical Data

The historical data trend for Quantum-Si's 3-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Quantum-Si 3-Year RORE % Chart

Quantum-Si Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
3-Year RORE %
- - - 29.81 -23.66

Quantum-Si Quarterly Data
Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
3-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 29.81 21.82 -13.04 -16.89 -23.66

Competitive Comparison of Quantum-Si's 3-Year RORE %

For the Biotechnology subindustry, Quantum-Si's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Quantum-Si's 3-Year RORE % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Quantum-Si's 3-Year RORE % distribution charts can be found below:

* The bar in red indicates where Quantum-Si's 3-Year RORE % falls into.



Quantum-Si 3-Year RORE % Calculation

Quantum-Si's 3-Year RORE % for the quarter that ended in Dec. 2023 is calculated as:

3-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 3-year -Cumulative Dividends per Share for 3-year )
=( -0.68--1.396 )/( -3.026-0 )
=0.716/-3.026
=-23.66 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Dec. 2023 and 3-year before.


Quantum-Si  (NAS:QSI) 3-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


Quantum-Si 3-Year RORE % Related Terms

Thank you for viewing the detailed overview of Quantum-Si's 3-Year RORE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Quantum-Si (Quantum-Si) Business Description

Traded in Other Exchanges
N/A
Address
530 Old Whitfield Street, Guilford, CT, USA
Quantum-Si Inc is focused on revolutionizing the growing field of proteomics. The company's suite of technologies is powered by a first-of-its-kind semiconductor chip designed to enable single-molecule next-generation protein sequencing and genomics, and digitize proteomic research in order to advance drug discovery and diagnostics beyond DNA sequencing.
Executives
Amir Jafri director C/O QUANTUM-SI INCORPORATED, 29 BUSINESS PARK DR., BRANFORD CT 06405
John P. Kenny director 3471 RIVER HILLS DRIVE, CINCINNATI OH 45244
Jeffry R. Keyes officer: Chief Financial Officer 13950 STOWE DRIVE, POWAY CA 92064-8803
Scott Mendel director 5964 LA PLACE COURT, ADDRESS 2, CARLSBAD CA 92008
Christian Lapointe officer: General Counsel & Corp. Secr. C/O QUANTUM-SI INCORPORATED, 530 OLD WHITFIELD STREET, GUILFORD CT 06437
Grace Johnston officer: Chief Commercial Officer C/O QUANTUM-SI INCORPORATED, 530 OLD WHITFIELD STREET, GUILFORD CT 06437
Kevin Rakin director, officer: Chairman and CEO 36 CHURCH LANE, WESTPORT CT 06880
Jeffrey Alan Hawkins director, officer: Chief Executive Officer 5964 LA PLACE COURT, CARLSBAD CA 92008
Vikram Bajaj director 600 MONTGOMERY STREET, SUITE 4500, SAN FRANCISCO CA 94111
Jonathan M Rothberg director, 10 percent owner C/O BUTTERFLY NETWORK, INC., 530 OLD WHITFIELD ST., GUILFORD CT 06437
Matthew Dyer officer: Chief Business Officer C/O QUANTUM-SI INCORPORATED, 530 OLD WHITFIELD STREET, GUILFORD CT 06437
Michael P Mckenna officer: President and COO C/O CURAGEN CORP, 555 LONG WHARF DR. 11TH FL., NEW HAVEN CT 06511
Patrick Schneider officer: President and COO C/O QUANTUM-SI INCORPORATED, 530 OLD WHITFIELD STREET, GUILFORD CT 06437
John Viii Stark director, officer: Chief Executive Officer C/O QUANTUM-SI INCORPORATED, 530 OLD WHITFIELD STREET, GUILFORD CT 06437
2012 Jmr Trust Common Llc 10 percent owner C/O QUANTUM-SI INCORPORATED, 530 OLD WHITFIELD STREET, GUILFORD CT 06437